Low plasma levels of dehydroepiandrosterone (DHEA) and incidence of lipodystrophy.
Piketty
C
C
Unité d'Immunologie Clinique and Université Pierre et Marie Curie, Hôpital Européen Georges Pompidou, France. christophe.piketty@egp.ap-hop-paris.fr
Jayle
D
D
Gonzalez-Canali
G
G
Debuire
B
B
Baulieu
E E
EE
Kazatchkine
M D
MD
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D001682:Biological Availability; D003687:Dehydroepiandrosterone / Q000008:administration & dosage* / Q000378:metabolism; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood*; D019587:Dietary Supplements; D018450:Disease Progression; D005260:Female; D015658:HIV Infections / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D006801:Humans; D015994:Incidence; D008060:Lipodystrophy / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D008297:Male; D012307:Risk Factors; D012449:Safety; D016896:Treatment Outcome
D003687:Dehydroepiandrosterone; D019314:Dehydroepiandrosterone Sulfate